Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2007
10/04/2007WO2007112402A1 Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
10/04/2007WO2007112093A2 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
10/04/2007WO2007112065A2 Methods for treating cognitive and other disorders
10/04/2007WO2007112014A2 New therapeutic combinations for the treatment of depression
10/04/2007WO2007112000A2 Treatment of pain
10/04/2007WO2007111982A2 Methods for treating cognitive and other disorders
10/04/2007WO2007111528A1 Agent exhibiting a neurotropic, neuromodulator, cerebrovascular and anti- stroke activity
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007WO2007111276A1 Novel ester derivative and use thereof
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007WO2007110730A2 Varenicline standards and impurity controls
10/04/2007WO2007110667A1 Piperidines and related compounds for the treatment of dementia
10/04/2007WO2007110636A1 Buprenorphine derivatives and uses thereof
10/04/2007WO2007110630A1 Thioninium compounds and their use
10/04/2007WO2007110629A1 Inhibitors of protein aggregation
10/04/2007WO2007110627A2 3,7-diamino-10h-phenothiazine salts and their use
10/04/2007WO2007110449A1 Benzenesulfonamide compounds and their use
10/04/2007WO2007110438A1 Imidazo [1,2 -b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007WO2007110437A1 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007WO2007110364A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007WO2007110335A1 Malonamide derivatives as gamma secretase inhibitors
10/04/2007WO2007110243A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut
10/04/2007WO2007110241A1 Plant extracts, plant components and the uses thereof
10/04/2007WO2007110221A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
10/04/2007WO2007110220A1 USE OF 4,9-ANHYDRO-TETRODOTOXIN FOR THE TREATMENT OF DISEASES RELATED TO THE VOLTAGE-GATED SODIUM CHANNEL α SUBUNIT NAV 1.6
10/04/2007WO2007110047A2 TERGURIDE/PROTERGURIDE FOR THE TREATMENT OF CHRONIC PAIN (e.g. MIGRAINE)
10/04/2007WO2007109851A1 Treatment of neurodegenerative diseases
10/04/2007WO2007092846A3 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
10/04/2007WO2007092839A3 Macrocycle derivatives useful as inhibitors of beta-secretase (bace)
10/04/2007WO2007091948A3 Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1
10/04/2007WO2007091947A3 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1
10/04/2007WO2007090881A3 Modified release formulation
10/04/2007WO2007085556A3 Use of 4-imidazole derivatives for cns disorders
10/04/2007WO2007084914A3 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/04/2007WO2007084424A3 Treatment of substance abuse
10/04/2007WO2007082726A3 Flowable leuprolide-containing composition for treating inflammation-mediated neurodegenerative diseases
10/04/2007WO2007079593A8 Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
10/04/2007WO2007077490A3 Bicyclic heteroaryl compounds as pde10 inhibitors
10/04/2007WO2007067581A8 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride
10/04/2007WO2007063385A3 Spirocyclic amine histamine-3 receptor antagonists
10/04/2007WO2007058805A3 Compositions and methods for treating cns disorders
10/04/2007WO2007049098A3 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/04/2007WO2007025177A3 Neurogenesis by muscarinic receptor modulation
10/04/2007WO2006030306A8 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007US20070232678 (4, 5, 6, 7-Tetrahydro-1-H-Indol-7-Yl) Acetic Acid Derivatives for Treatment of Alzheimer's Disease
10/04/2007US20070232659 Novel Alkyl Substituted Piperidine Derivatives as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/04/2007US20070232656 Pharmaceutical Composition And Method For Treating Neurodegenerative Disorders
10/04/2007US20070232642 2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of beta-secretase (bace)
10/04/2007US20070232629 Adhesive Patch
10/04/2007US20070232618 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232584 Composition and Method for the Treatment of Tauopathies
10/04/2007US20070232580 Novel sterol/stanol nitroderivatives and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
10/04/2007US20070232564 Fish-Origin Chondroitin Sulfate/Dermatan Sulfate Hybrid Chain
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232538 Uses of polypeptides
10/04/2007US20070232535 GFRalpha3 and its uses
10/04/2007US20070231898 culturing in a mixture of fibroblast growth factor, thyroid hormone, and retinoic acid; differentiated cell population which generate glial cells for treating central nervous system traumas and disorders
10/04/2007US20070231863 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231376 Methods and compositions for modulating axonal outgrowth of central nervous system neurons
10/04/2007US20070231350 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine
10/04/2007US20070231349 immunogenically active component of West Nile virus or plasmid DNA which is pCBWN, an adjuvant such as a metabolizable oil, and a pharmacologically acceptable carrier are formulated into an immunizing vaccine for preventing West Nile disease, such as encephalitis in equine
10/04/2007US20070231309 Cell populations which co-express CD49c and CD90
10/04/2007US20070231269 Analgesics
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007US20070231266 Diagnosis of macrophage mediated disease
10/04/2007US20070227146 Thermal energy storage
10/04/2007DE202007007542U1 Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Arzneimittel zur Behandlung von Demenzerkrankungen Amino acid-mineral-peptide complex, in particular quantum mechanically modified as drugs for the treatment of dementia
10/04/2007DE102006016285A1 Medicament used to reduce risk of e.g. heart disease and urinary tract disease, comprises 5-methyl-(6S)-tetrahydrofolate, estrogen and/or gestagene, vitamin B6 and/or vitamin B2 and auxiliary or carrier materials
10/04/2007DE102006014390A1 Assoziate von Xanthogenaten mit Cyclodextrinen und ihre Verwendung Associates of xanthates with cyclodextrins and their use
10/04/2007DE102006013307B3 Tergurid/Protergurid zur Behandlung von chronischen Schmerzen Terguride / proterguride for the treatment of chronic pain
10/04/2007CA2647603A1 Ureide derivative and use thereof for medical purposes
10/04/2007CA2647512A1 Substance exhibiting neuromodulator activity
10/04/2007CA2647417A1 Buprenorphine derivatives and uses thereof
10/04/2007CA2647290A1 Piperidines and related compounds for the treatment of dementia
10/04/2007CA2647235A1 Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
10/04/2007CA2647116A1 Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as gaba receptor ligands
10/04/2007CA2647048A1 Methods for treating cognitive and other disorders
10/04/2007CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007CA2646700A1 Terguride/proterguride for the treatment of chronic pain
10/04/2007CA2645946A1 Inhibitors of protein aggregation
10/04/2007CA2645919A1 Thioninium compounds and their use
10/04/2007CA2645756A1 Malonamide derivatives as gamma secretase inhibitors
10/04/2007CA2645581A1 Benzothiazoles having histamine h3 receptor activity
10/04/2007CA2644662A1 New therapeutic combinations for the treatment of depression
10/04/2007CA2644656A1 Treatment of pain
10/04/2007CA2644639A1 New therapeutic combinations for the treatment or prevention of psychotic disorders
10/04/2007CA2644618A1 Methods for treating cognitive and other disorders
10/04/2007CA2644448A1 Varenicline standards and impurity controls
10/04/2007CA2644441A1 Treatment of neurodegenerative diseases
10/04/2007CA2644369A1 Amide derivatives and their application for the treatment of g protein related diseases
10/03/2007EP1840126A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1840117A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
1 ... 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 ... 1833